Benefits
Equivalent to whey for muscle and strength gains
A meta-analysis found NO difference between soy and whey protein supplementation for strength gains (bench press, squat) or lean body mass gains when paired with resistance training. Despite acute MPS being higher with whey, long-term outcomes converge — the protein source matters less than total daily protein adequacy.
LDL cholesterol reduction (FDA-recognized heart health claim)
A meta-analysis found 47 g/day soy protein reduced total cholesterol 9.3%, LDL-c 12.9%, and triglycerides 10.5% vs animal protein. Subsequent meta-analyses found smaller but consistent ~3-4% LDL reduction. FDA authorized a heart health claim in 1999 for products providing ≥6.25 g soy protein per serving (25 g/day total).
Complete amino acid profile
Soy is one of few plant proteins with a complete essential amino acid profile (PDCAAS = 1.0, the highest score). Especially relevant for vegetarian and vegan athletes seeking adequate leucine, lysine, and methionine without combining multiple plant sources.
Sustained satiety and weight management
Soy protein produces similar satiety and weight management outcomes to dairy protein in controlled trials. The protein-induced thermic effect, GLP-1 release, and gastric emptying delay are comparable. Useful for those preferring plant-based protein for ethical, environmental, or lactose-intolerance reasons.
Mechanism of action
mTOR/protein synthesis pathway activation
Like other complete proteins, soy provides leucine to activate mTORC1/p70S6K signaling and trigger muscle protein synthesis. Soy has slightly lower leucine content (~8%) than whey (~11%), producing a smaller acute MPS spike, but cumulative 24-hour protein synthesis equalizes when daily protein intake is adequate (~1.6-2.2 g/kg in trained athletes).
Apolipoprotein B reduction (cholesterol mechanism)
Soy protein reduces hepatic LDL-c output via decreased apolipoprotein B (apoB) secretion and increased LDL receptor expression — opposite mechanism to dietary saturated fat. Replacement of animal protein/saturated fat with soy further amplifies the LDL benefit through dietary substitution.
Isoflavone weak ER binding (in non-isolated forms)
Soy concentrate retains isoflavones (genistein, daidzein) that bind weakly to estrogen receptors (preferentially ERβ over ERα). At typical dietary intakes, the activity is selective estrogen receptor modulator-like, contributing to vasomotor symptom reduction in menopausal women but generally not affecting male hormone profiles. Soy protein isolate is largely depleted of isoflavones during processing.
Clinical trials
Random-effects pooled analysis (Messina, Lynch, Dickinson, Int J Sport Nutr Exerc Metab 28(6):674-685).
9 randomized trials, 266 participants total. 5 trials compared whey vs soy protein; 4 trials compared soy vs other animal proteins (beef, milk, dairy). All paired with resistance exercise training.
No difference between soy and animal protein for strength gains (bench press χ²=0.02, p=0.90; squat χ²=0.22, p=0.64) or lean body mass gains (whey vs soy χ²=0.00, p=0.96; other proteins vs soy χ²=0.06, p=0.80). Both groups showed significant strength and LBM increases vs control. Authors concluded soy protein supplementation produces similar resistance-exercise outcomes to whey or other animal proteins.
Random-effects pooled analysis with hierarchical mixed-effects regression (Anderson, Johnstone, Cook-, N Engl J Med 333(5):276-282).
38 controlled clinical trials evaluating soy protein vs animal protein on serum lipids in humans. Mean intake 47 g/day soy protein.
Soy protein consumption decreased: total cholesterol 23.2 mg/dL (-9.3%, 95% CI 13.5-32.9), LDL-c 21.7 mg/dL (-12.9%, 95% CI 11.2-31.7), and triglycerides 13.3 mg/dL (-10.5%, 95% CI 0.3-25.7). HDL-c showed nonsignificant increase. The pivotal evidence underlying the FDA's 1999 soy protein heart health claim (25 g/day for cholesterol reduction).
Acute muscle protein synthesis study using stable isotope tracers (Tang, Moore, Kujbida, Tarnopolsky, J Appl Physiol 107(3):987-992).
3 groups of 6 healthy young men. Each group performed unilateral leg resistance exercise then consumed 10 g essential amino acids equivalent as whey hydrolysate, micellar casein, or soy protein isolate.
Mixed muscle protein synthesis at rest: whey 0.091 ± 0.015 vs soy 0.078 ± 0.014 vs casein 0.047 ± 0.008 %/h. Soy intermediate between whey and casein in acute MPS response. After resistance exercise, MPS was greater after whey or soy than casein. Established whey's acute superiority, but established soy as a viable option that outperformed casein.
Cumulative pooled analysis of FDA-identified soy protein studies (Blanco Mejia, Messina, Li, Viguiliouk, Chiavaroli, Khan, Srichaikul, Mirrahimi, Sievenpiper, Kris-Etherton, J Nutr 149(6):968-981).
46 trials examining soy protein effects on circulating LDL-c and total cholesterol, identified by FDA for heart health claim review.
Pooled effect: soy protein reduced LDL-c 4.2 mg/dL (-3.2%, p<0.0001) and total cholesterol 6.4 mg/dL (-2.8%, p<0.0001). Effect smaller than estimate but consistent and reproducible. Combined with food-substitution advantages (reducing saturated fat in displaced animal protein), real-world LDL reduction may approach 6-10%. Authors concluded soy protein remains a clinically useful adjunct to dietary cholesterol management.